Dominique Monnet's Net Worth
$528 Thousand
Who is Dominique Monnet?
Dominique Monnet does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Evofem Biosciences, Inc., PDL BIOPHARMA, INC., and ALEXION PHARMACEUTICALS INC.
SEC CIK
Dominique Monnet's CIK is 0001632798
Past Insider Trading and Trends
2019 was Dominique Monnet's most active year for acquiring shares with 4 total transactions. Dominique Monnet's most active month to acquire stocks was the month of February. 2015 was Dominique Monnet's most active year for disposing of shares, totalling 2 transactions. Dominique Monnet's most active month to dispose stocks was the month of January. 2019 saw Dominique Monnet paying a total of $3,282,498.24 for 5,782,392 shares, this is the most they've acquired in one year. In 2020 Dominique Monnet cashed out on 1,172,505 shares for a total of $3,660,492.55, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Evofem Biosciences, Inc. (EVFM) Snapshot price: $0.0099
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
President and CEODominique Monnet owns 734,921 units of Common stock.acquired a total of 3,590,124 shares in PDL BIOPHARMA, INC. at a cost of $3,282,498.24, Dominique also disposed a total of 1,190,120 shares of PDL BIOPHARMA, INC. equalling to $3,713,689.85.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -40.49% | -500.00K |
$2.60 | -$1,300,000.00 | 734.92K |
Dec 16
| |||
Form 4/A
| +183.14% | 1.23M |
—
|
—
| 1.91M |
Jan 8
| |||
Form 4
| -35.26% | -672.50K |
$3.51 | -$2,360,492.55 | 1.23M |
Feb 7
| |||
Form 4
| +183.14% | 1.23M |
—
|
—
| 1.91M |
Jan 8
| |||
Form 4/A
| +202.65% | 451.07K |
$3.72 | $1,677,999.00 | 673.66K |
Mar 28
| |||
Form 4
| +193.78% | 431.32K |
$3.72 | $1,604,499.24 | 653.9K |
Mar 28
| |||
Form 4
| -7.33% | -17.61K |
$3.02 | -$53,197.30 | 222.59K |
Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
|
∞
| 240.2K |
—
|
—
| 240.2K |
Sep 11 - Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALEXION PHARMACEUTICALS INC No price found
SVP, Chief Marketing OfficerDominique Monnet owns 8,787 units of Common Stock, par value $.0001 per share. In the year 2015 Dominique Monnet filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.83% | -256.00 |
$162.40 | -$41,574.40 | 8.79K |
May 20
| |||
Form 4
| +73.47% | 3.83K |
—
|
—
| 9.04K |
Feb 27
| |||
Form 4
| -5.87% | -325.00 |
$171.15 | -$55,623.75 | 5.21K |
Feb 10
| |||
Form 4
| +84.60% | 2.54K |
—
|
—
| 5.54K |
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||